Cancer espionage - from bombs to spies

Under the knife with Prof Carol-Ann Benn. Prof Carol-Ann Benn likens the latest oncology drugs to treat breast cancer to snipers and spies and explains why they have a good kill-ability. This episode is brought to you by Accord Healthcare in the interest of education, awareness, and support. The content and opinions expressed are entirely those of the healthcare professional and not influenced by Accord Healthcare in any way. Accord Healthcare is one of the fastest-growing generic pharmaceutical companies with a direct presence in all major markets, Americas, the EU, Asia, and Africa. Accord Healthcare is an Oncology leader with a 30% global volume share of major chemotherapy molecules. The cornerstone of Accord’s offering to the South African market is exceptional quality, affordability and service to healthcare professionals and their patients. Prof Carol-Ann Benn heads up an internationally accredited, multi-disciplinary breast cancer centre at Netcare Milpark Hospital. She lectures at Wits University and, in 2002, established the Breast Health Foundation. Read more on Buddies for Life